HGXIX
Price
$19.41
Change
-$0.00 (-0.00%)
Updated
Sep 4 closing price
Net Assets
352.58M
RSLCX
Price
$76.96
Change
+$0.88 (+1.16%)
Updated
Sep 3 closing price
Net Assets
89.02B
Interact to see
Advertisement

HGXIX vs RSLCX

HGXIX vs RSLCX Comparison Chart in %
View a ticker or compare two or three
VS
HGXIX vs. RSLCX commentary
Sep 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGXIX is a Buy and RSLCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLCX has more cash in the bank: 89B vs. HGXIX (353M). HGXIX pays higher dividends than RSLCX: HGXIX (0.47) vs RSLCX (0.43). HGXIX was incepted earlier than RSLCX: HGXIX (10 years) vs RSLCX (24 years). RSLCX (1.30) is less costly to investors than HGXIX (0.88). HGXIX is a more actively managed with annual turnover of: 44.00 vs. RSLCX (41.00). RSLCX has a lower initial minimum investment than HGXIX: RSLCX (250) vs HGXIX (2000). HGXIX (12.41) and RSLCX (12.29) have marching annual gain over last year. HGXIX return over 5 years is better than : 13.12 vs. RSLCX (-11.79).
HGXIXRSLCXHGXIX / RSLCX
Total Expense Ratio0.881.3068%
Annual Report Gross Expense Ratio0.881.3068%
Fund Existence10 years24 years-
Gain YTD15.74213.043121%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets353M89B0%
Annual Yield % from dividends0.470.43108%
Returns for 1 year12.4112.29101%
Returns for 3 years51.7533.37155%
Returns for 5 years13.12-11.79-111%
Returns for 10 yearsN/A73.96-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TWCCX61.750.89
+1.46%
American Century Ultra® C
PHPIX47.80N/A
N/A
ProFunds Pharmaceuticals UltraSector Inv
GSELX74.67N/A
N/A
Goldman Sachs US Equity Insights Instl
FFECX16.47N/A
N/A
Nuveen Dividend Value C
MAVKX16.53N/A
N/A
MoA Small Cap Value Fund